Le Lézard
Classified in: Transportation, Health, Science and technology

DuPont launches new DuPonttm Liveotm Pharma Bottle Closures


WILMINGTON, Del., Oct. 14, 2021 /PRNewswire-PRWeb/ -- DuPont (NYSE:DD) today introduced its new DuPonttm Liveotm Pharma Bottle Closures ? one-piece silicone stoppers and tubings made from biomedical-grade silicone elastomers ? as a welcome addition to its existing overmolded assembly portfolio for biopharma processing applications.

Liveotm Pharma Bottle Closures are designed specifically to seal threaded glass and plastic bottles and containers used for critical fluid transfer, media and buffer pooling and storage, and sample collection in biopharmaceutical and biotechnology processes.

"Adding a complementary range to the Liveotm Pharma Overmolded Assemblies (OMA) line demonstrates our commitment to meeting customer requirements in terms of supply flexibility and broader portfolio solutions," said Michele Vigliotti, Regional Marketing Manager EMEA, DuPont Healthcare. "And the new pharma bottle closures deliver the same promises of product purity, performance, quality and reliability as the rest of our pharma product line."

Liveotm Pharma Bottle Closures include a one-piece silicone seal part made from biomedical-grade platinum-cured silicone elastomer molded with high-purity platinum-cured silicone tubing. This makes the product particularly suitable for preventing leak and contamination risk.

Both the silicone extruded tubing and molded parts are constructed with biomedical-grade silicone elastomers formulated and compounded by DuPont to enable high purity by design.

The one-piece silicone seal part is designed to the end user's specific needs and is manufactured and packaged in a strictly controlled clean manufacturing environment at the company's FDA-registered Healthcare Industries Materials Site (HIMS) in Michigan, USA, which is dedicated to the manufacture of silicone-based materials for pharma and medical devices.

Liveotm Pharma Bottle Closures meet the highest standards in terms of biocompatibility and regulatory requirements and can be sterilized by autoclave and gamma irradiation for use in aseptic environments.

The cured silicone seal parts currently are available for GL45 and 38-430 neck bottles and containers. Silicone tubing is available in Shore A durometers of 50, 65 and 80. A range of tubing lengths and diameters can be accommodated according to the end-user's specific needs. The number and dimensions of tubing pieces molded to the seal part are determined by the closure size. Customized tolerances to meet customers' specific application requirements are available upon request. An external polypropylene cap is supplied with the silicone closure assembly.

The new closures will be showcased at three upcoming biopharmaceutical industry events: CBioPC in Nanjing, China, on October 15 and 16; INTERPHEX in New York, New York, USA, October 19 through 21; and CPhI in Milan, Italy, November 19 through 21.

About DuPonttm Liveotm Healthcare Solutions
DuPonttm Liveotm is a globally recognized leader in technology for a broad range of innovations in medical devices, biopharmaceutical processing and pharmaceutical solutions. DuPont high-performance materials help create safer healthcare environments and protect the health of patients and healthcare providers worldwide. We help enable smarter healthcare and positive patient outcomes. More information can be found at liveo.dupont.com.

About DuPont Electronics & Industrial
DuPont Electronics & Industrial is a global supplier of new technologies and performance materials serving the semiconductor, circuit board, display, digital and flexographic printing, healthcare, aerospace, industrial, and transportation industries. From advanced technology centers worldwide, teams of talented research scientists and application experts work closely with customers, providing solutions, products and technical service to enable next-generation technologies.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

# # #

DuPonttm, the DuPont Oval Logo, and all trademarks and service marks denoted with tm, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

10/14/21

Media Contact

Fiona Paul Pinter, DuPont, +41 79 5713084, [email protected]

 

SOURCE DuPont


These press releases may also interest you

at 07:00
LifeLabs workers from Orillia, Barrie, Collingwood, and Wasaga Beach will rally with community members and allies ahead of their imminent strike deadline. They stand firm in their demands for a fair contract that puts patients and workers before...

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...



News published on and distributed by: